Pharma

Selected news for the healthcare topic - Pharma, collected since 6/2021. There are 75.1K items in the archive. This healthcare topic shares news with COVID-19, Biotech, Zacks Investment Research, Pfizer, Life Sciences and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
5/22/2022 Big Pharma lobbies for slice of G20 fund to prepare for next pandemic - News07trends universalpersonality.com Large Pharma is providing to order vaccines, medicines and assessments for low-income nations in preparation for the following pandemic in change for a charge and a dedication that governments not impose restrictions on commerce.Forward of talks on pandemic preparedness on the World Well being Group subsequent week, the trade is lobbying to win a slice of a multibillion-dollar pandemic preparedness fund proposed by the G20 to cowl ...
5/22/2022 Big Pharma lobbies for slice of G20 fund to prepare for next pandemic writecaliber.com Big Pharma lobbies for slice of G20 fund to prepare for next pandemic- Date: 22-May-2022- Source: Financial Times- Sector: [Financial Markets]- Country: [Saudi Arabia]Big Pharma lobbies for slice of G20 fund to prepare for next pandemicBig Pharma is offering to reserve vaccines, medicines and tests for low-income nations in preparation for the next pandemic in exchange for a fee and a commitment that governments not ...
5/22/2022 Big Pharma lobbies for slice of G20 fund to prepare for next pandemic - News Bit newsbit.us Business By Dustin Moskovitz On May 22, 2022 0 Share Big Pharma is offering to reserve vaccines, medicines and tests for low-income nations in preparation for the next pandemic in exchange for a fee and a commitment that governments not impose restrictions on trade. Ahead of talks on pandemic preparedness at the World Health Organization next week, the industry is lobbying to win a slice of a multibillion-dollar ...
5/22/2022 Oyster Point Pharma (NASDAQ:OYST) vs. Qiagen (NASDAQ:QGEN) Financial Survey - Ticker Report Ticker Report Oyster Point Pharma ( NASDAQ:OYST – Get Rating ) and Qiagen ( NASDAQ:QGEN – Get Rating ) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability.Analyst RecommendationsGet Oyster Point Pharma alerts: This is a summary of current ratings for Oyster Point Pharma and Qiagen, as provided by ...
5/22/2022 aTyr Pharma, Inc. (NASDAQ:LIFE) Expected to Announce Earnings of -$0.44 Per Share - Transcript Daily transcriptdaily.com Brokerages predict that aTyr Pharma, Inc. ( NASDAQ:LIFE – Get Rating ) will report earnings per share of ($0.44) for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for aTyr Pharma’s earnings. The highest EPS estimate is ($0.36) and the lowest is ($0.48). aTyr Pharma reported earnings per share of ($0.64) in the same quarter last year, which would suggest a positive year-over-year growth rate ...
5/22/2022 Zacks: Brokerages Expect Albireo Pharma, Inc. (NASDAQ:ALBO) Will Announce Earnings of -$1.58 Per Share dispatchtribunal.com Brokerages expect that Albireo Pharma, Inc. ( NASDAQ:ALBO – Get Rating ) will announce earnings of ($1.58) per share for the current quarter, Zacks reports. Four analysts have made estimates for Albireo Pharma’s earnings, with the highest EPS estimate coming in at ($0.76) and the lowest estimate coming in at ($1.95). Albireo Pharma reported earnings of ($1.90) per share in the same quarter last year, which would indicate a positive ...
5/22/2022 aTyr Pharma, Inc. (NASDAQ:LIFE) Expected to Post Earnings of -$0.44 Per Share modernreaders.com Brokerages expect aTyr Pharma, Inc. ( NASDAQ:LIFE – Get Rating ) to post ($0.44) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for aTyr Pharma’s earnings. The lowest EPS estimate is ($0.48) and the highest is ($0.36). aTyr Pharma posted earnings per share of ($0.64) during the same quarter last year, which would suggest a positive year over year growth rate of ...
5/22/2022 Brokerages Anticipate Albireo Pharma, Inc. (NASDAQ:ALBO) Will Post Quarterly Sales of $9.42 Million thelincolnianonline.com Brokerages expect Albireo Pharma, Inc. ( NASDAQ:ALBO – Get Rating ) to post $9.42 million in sales for the current fiscal quarter, according to Zacks Investment Research . Four analysts have provided estimates for Albireo Pharma’s earnings, with the highest sales estimate coming in at $10.23 million and the lowest estimate coming in at $8.14 million. Albireo Pharma posted sales of $2.43 million during the same quarter last year, which suggests ...
5/22/2022 $380,000.00 in Sales Expected for Cocrystal Pharma, Inc. (NASDAQ:COCP) This Quarter Mayfield Recorder Equities research analysts expect Cocrystal Pharma, Inc. ( NASDAQ:COCP – Get Rating ) to post sales of $380,000.00 for the current fiscal quarter, according to Zacks Investment Research . Two analysts have issued estimates for Cocrystal Pharma’s earnings, with the lowest sales estimate coming in at $250,000.00 and the highest estimate coming in at $500,000.00. The business is scheduled to report its next earnings report on Monday, January 1st.According to ...
5/22/2022 Zacks: Analysts Expect Cocrystal Pharma, Inc. (NASDAQ:COCP) Will Post Quarterly Sales of $380,000.00 modernreaders.com Wall Street analysts predict that Cocrystal Pharma, Inc. ( NASDAQ:COCP – Get Rating ) will announce sales of $380,000.00 for the current fiscal quarter, according to Zacks Investment Research . Two analysts have made estimates for Cocrystal Pharma’s earnings. The lowest sales estimate is $250,000.00 and the highest is $500,000.00. The business is expected to announce its next earnings results on Monday, January 1st.On average, analysts expect that Cocrystal Pharma ...
5/22/2022 Terns Pharmaceuticals (NASDAQ:TERN) & Albireo Pharma (NASDAQ:ALBO) Critical Contrast zolmax.com Terns Pharmaceuticals ( NASDAQ:TERN – Get Rating ) and Albireo Pharma ( NASDAQ:ALBO – https://report.stocknews.com/sign-up/ticker/?ticker=ALBO&leadsource=marketbeatsnra&utmsource=marketbeatsnra&utmmedium=article&utmcampaign=ticker&utmterm=ALBO&utmcontent=text_link ) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst ...
5/22/2022 Gabriele Cerrone Acquires 5,800,000 Shares of OKYO Pharma Limited (LON:OKYO) Stock com-unik.info OKYO Pharma Limited ( LON:OKYO – Get Rating ) insider Gabriele Cerrone purchased 5,800,000 shares of the business’s stock in a transaction that occurred on Thursday, May 19th. The stock was bought at an average cost of GBX 6 ($0.07) per share, for a total transaction of £348,000 ($428,994.08).Shares of LON OKYO opened at GBX 4.36 ($0.05) on Friday. The company has a market cap of £59.92 million and ...
5/22/2022 Gabriele Cerrone Acquires 5,800,000 Shares of OKYO Pharma Limited (LON:OKYO) Stock - Ticker Report Ticker Report OKYO Pharma Limited ( LON:OKYO – Get Rating ) insider Gabriele Cerrone purchased 5,800,000 shares of the business’s stock in a transaction that occurred on Thursday, May 19th. The stock was bought at an average cost of GBX 6 ($0.07) per share, for a total transaction of £348,000 ($428,994.08).Shares of LON OKYO opened at GBX 4.36 ($0.05) on Friday. The company has a market cap of £59.92 million and ...
5/22/2022 Head-To-Head Review: Oncology Pharma (OTCMKTS:ONPH) & Zenvia (NASDAQ:ZENV) - Ticker Report Ticker Report Zenvia ( NASDAQ:ZENV – Get Rating ) and Oncology Pharma ( OTCMKTS:ONPH – Get Rating ) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability and dividends.Valuation & EarningsGet Zenvia alerts: This table compares Zenvia and Oncology Pharma’s top-line revenue, earnings per share (EPS) and ...
5/22/2022 Gujarat: Fire in Gandhinagar pharma factory; no casualty indiatvnews.com A major fire broke out in a drug manufacturing factory in Gujarat's Gandhinagar district on Sunday. There was no report of any casualty. The blaze erupted in the pharmaceutical unit located in Kalol industrial area, an official from the fire department in Gandhinagar said. A call was received about the blaze around 9 am and five fire tenders were rushed there immediately, the official said.The fire spread fast due ...
5/22/2022 Inozyme Pharma (NASDAQ:INZY) Upgraded to Buy at Zacks Investment Research - Mayfield Recorder Mayfield Recorder Zacks Investment Research upgraded shares of Inozyme Pharma ( NASDAQ:INZY – Get Rating ) from a hold rating to a buy rating in a research note issued to investors on Wednesday, Zacks.com reports. They currently have $4.50 price target on the stock.According to Zacks, “Inozyme Pharma Inc. is a biopharmaceutical company. It engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue and skeleton diseases. The company ...
5/22/2022 Antares Pharma (NASDAQ:ATRS) Rating Lowered to Hold at Zacks Investment Research thelincolnianonline.com Zacks Investment Research downgraded shares of Antares Pharma ( NASDAQ:ATRS – Get Rating ) from a buy rating to a hold rating in a research note released on Wednesday morning, Zacks.com reports.According to Zacks, “Antares Pharma, Inc. develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life ...
5/22/2022 aTyr Pharma (NASDAQ:LIFE) PT Lowered to $11.00 zolmax.com aTyr Pharma ( NASDAQ:LIFE – Get Rating ) had its price objective cut by Piper Sandler from $19.00 to $11.00 in a research note published on Wednesday morning, The Fly reports. They currently have an overweight rating on the biotechnology company’s stock.LIFE has been the topic of several other research reports. Zacks Investment Research raised aTyr Pharma from a hold rating to a buy rating and set a $4.00 ...
5/22/2022 aTyr Pharma (NASDAQ:LIFE) PT Lowered to $11.00 baseballnewssource.com aTyr Pharma ( NASDAQ:LIFE – Get Rating ) had its price objective decreased by Piper Sandler from $19.00 to $11.00 in a report released on Wednesday, The Fly reports. Piper Sandler currently has an overweight rating on the biotechnology company’s stock.A number of other brokerages have also commented on LIFE. StockNews.com lowered aTyr Pharma from a hold rating to a sell rating in a research note on Tuesday, April ...
5/22/2022 Zealand Pharma A/S (NASDAQ:ZEAL) Raised to “Buy” at Zacks Investment Research - Ticker Report Ticker Report Zacks Investment Research upgraded shares of Zealand Pharma A/S ( NASDAQ:ZEAL – Get Rating ) from a hold rating to a buy rating in a research note published on Thursday morning, Zacks.com reports. They currently have $13.00 price objective on the stock.According to Zacks, “Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. Zealand Pharma A/S is ...